News

Ablynx said that this is the first lead candidate emerging from the Alzheimer’s disease collaboration between Ablynx and Boehringer Ingelheim and is expected to result in a EUR2m

Can-Fite claimed that its CF101 is a targeted drug that specifically attacks diseased or pathologic cells without compromising normal body systems, and therefore has shown a favorable safety

Bayer HealthCare said that the results of the study of investigational drug gadobutrol met all of its pre-specified primary efficacy objectives. Gadobutrol is investigational in the US and

The financing was led by investor, Care Capital, with participation from existing venture investor Index Ventures. The new round of financing brings the total capital raised by NormOxys

MEDI-528 is a humanized antibody targeting IL-9, which is a member of a family of inflammatory signaling molecules known as interleukins. Several of these interleukin molecules, including IL-9,

According to Abviva, the Japanese Patent Office had issued two patents on the core breast cancer risk assessment technology that may be used for therapeutic applications and in

FDA issued Import Alert no 66-38, ‘Skin Care Products Labeled As Anti-Aging Creams’ (IA 66-38) in 1988, subjecting cosmetic manufacturers, including several large, non-US cosmetics importers Estee Lauder,

Gross profit increased by 69% year-over-year to $3,799,354. As a result of GMP inspection, production had been temporarily suspended during the period ended March 31, 2010, and the

Wellstat Therapeutics said that while no antidote for 5-FU overexposure has been approved by regulatory authorities, Uridine triacetate (formerly known as vistonuridine) has been made available to physicians